Novartis India Ltd.

View in App
734.80 -2.25 ▼-0.3%

21 September 2023, 04:01:00 PM
Volume: 453

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.novartis.in
Market Cap 1,814.16 Cr.
Enterprise Value(EV) 1,258.22 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 28.85 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 25.47 Trailing Twelve Months Ending 2023-06
Industry PE 37.95 Trailing Twelve Months Ending 2023-06
Book Value / Share 322.37 Trailing Twelve Months Ending 2023-06
Price to Book Value 2.28 Calculated using Price: 734.75
Dividend Yield 6.46 Period Ending 2023-03
No. of Shares Subscribed 2.47 Cr. 24,690,797 Shares
FaceValue 5
About Novartis India Ltd.
Novartis has been in India since 1947. The Group operates in India through four entities namely Novartis India Limited, listed on the Mumbai Stock Exchange, Novartis Healthcare Private Limited, Sandoz Private Limited and Chiron-Behring Vaccine Private Limited. In India Novartis have a presence in pharmaceuticals, generics (pharmaceutical products that are off patent), Vaccines, OTC (over-the-counter medicines), eyecare and Animal Health.

Novartis India Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Novartis India Ltd. Performance

View details >>
1 Day
-0.31%
1 Week
-2.35%
1 Month
+3.13%
3 Month
-10.09%
6 Month
+28.59%
1 Year
+5.66%
2 Year
-9.71%
5 Year
-7.60%
10 Year
+86.50%

Novartis India Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 8.06 18.01 5.38 9.40 6.89 1.36 2.91 -0.53 14.07
Return on Capital Employed (%) 9.52 24.77 8.75 19.72 11.70 4.73 6.67 0.14 15.96
Return on Assets (%) 3.89 11.38 3.27 3.75 2.51 0.62 1.22 -0.18 5.09

Novartis India Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 961 1,002 1,194 920 734 759 721 711 692 776
Non Curr. Liab. 586 697 26 828 898 891 99 1,131 984 1,008
Curr. Liab. 459 362 204 323 482 367 417 357 334 268
Minority Int.
Equity & Liab. 2,006 2,060 1,425 2,070 2,113 2,018 1,237 2,199 2,010 2,052
Non Curr. Assets 698 846 161 959 1,009 1,029 240 1,277 1,183 1,266
Curr. Assets 1,308 1,215 1,264 1,111 1,104 989 997 922 826 786
Misc. Exp. not W/O
Total Assets 2,006 2,060 1,425 2,070 2,113 2,018 1,237 2,199 2,010 2,052

Novartis India Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 873 690 656 564 491 438 381 400 379 348
Other Income 112 245 72 174 78 36 34 34 58 44
Total Income 985 934 728 738 569 475 416 433 437 392
Total Expenditure -881 -659 -632 -572 -479 -427 -356 -373 -314 -298
PBIDT 104 275 96 166 91 48 60 60 123 95
Interest 0 0 -1 -6 -2 -6 -8 -5 -2 -2
Depreciation -4 -3 -4 -3 -3 -13 -12 -10 -6 -6
Taxation -14 -73 -35 -79 -34 -19 -19 0 -12 -15
Exceptional Items -6 -50
PAT 79 198 57 78 52 10 21 -4 103 71
Adjusted EPS 25 62 20 32 21 4 8 -2 42 29

Novartis India Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -5 -60 57 -41 161 -194 -23 -69 39 45
Cash Fr. Inv. 22 719 -630 424 69 274 56 95 87 -153
Cash Fr. Finan. -38 -38 -39 -332 -268 -30 -41 -37 -36 -30
Net Change -20 622 -612 51 -38 50 -9 -11 90 -139
Cash & Cash Eqvt 15 637 25 76 38 88 79 68 158 19

Novartis India Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 70.68 70.68 70.68 70.68 70.68 70.68 70.68 70.68 70.68
Public 29.32 29.32 29.32 29.32 29.32 29.32 29.32 29.32 29.32
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Novartis India Ltd. Announcements

View details >>
Thu, 21 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Thu, 21 Sep 2023
Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for the financial year 2022-23
Wed, 20 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015

Novartis India Ltd. Technical Scans

View details >>
Thu, 21 Sep 2023
High Delivery Percentage High Delivery Percentage
Making Lower Lows for 3 days Making Lower Lows for 3 days
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 6 Months High Increase in 6 Months

Novartis India Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 274,963.79 1,148.50 -0.4%
Divi's Laboratories Ltd. 99,404.71 3,741.45 -1.0%
Cipla Ltd. 97,455.33 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. 94,594.48 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. 72,171.99 5,023.50 +0.4%
Mankind Pharma Ltd. 69,708.40 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. 63,451.75 1,874.80 -0.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.67 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-06 67.23 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-06 31.32 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 20.07 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 108.04 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 54.38 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.36 1,874.80 -0.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.75 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-06 7.57 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-06 4.00 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.86 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.52 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 5.69 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.65 1,874.80 -0.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 0.02 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,874.80 -0.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,874.80 -0.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,874.80 -0.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,874.80 -0.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,874.80 -0.5%

Novartis India Ltd. FAQ's

What is Novartis share price?
Can I buy Novartis shares now?
What is the Dividend Yield of Novartis?
What is the Market Cap of Novartis?
What are the key metrics to analyse Novartis?
What is the 52 Week High and Low of Novartis?
What is the trend of Novartis share price?